These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

692 related articles for article (PubMed ID: 29768147)

  • 1. As-Needed Budesonide-Formoterol versus Maintenance Budesonide in Mild Asthma.
    Bateman ED; Reddel HK; O'Byrne PM; Barnes PJ; Zhong N; Keen C; Jorup C; Lamarca R; Siwek-Posluszna A; FitzGerald JM
    N Engl J Med; 2018 May; 378(20):1877-1887. PubMed ID: 29768147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled Combined Budesonide-Formoterol as Needed in Mild Asthma.
    O'Byrne PM; FitzGerald JM; Bateman ED; Barnes PJ; Zhong N; Keen C; Jorup C; Lamarca R; Ivanov S; Reddel HK
    N Engl J Med; 2018 May; 378(20):1865-1876. PubMed ID: 29768149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a single day of increased as-needed budesonide-formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 study.
    O'Byrne PM; FitzGerald JM; Bateman ED; Barnes PJ; Zheng J; Gustafson P; Lamarca R; Puu M; Keen C; Alagappan VKT; Reddel HK
    Lancet Respir Med; 2021 Feb; 9(2):149-158. PubMed ID: 33010810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial.
    Hardy J; Baggott C; Fingleton J; Reddel HK; Hancox RJ; Harwood M; Corin A; Sparks J; Hall D; Sabbagh D; Mane S; Vohlidkova A; Martindale J; Williams M; Shirtcliffe P; Holliday M; Weatherall M; Beasley R;
    Lancet; 2019 Sep; 394(10202):919-928. PubMed ID: 31451207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled Trial of Budesonide-Formoterol as Needed for Mild Asthma.
    Beasley R; Holliday M; Reddel HK; Braithwaite I; Ebmeier S; Hancox RJ; Harrison T; Houghton C; Oldfield K; Papi A; Pavord ID; Williams M; Weatherall M;
    N Engl J Med; 2019 May; 380(21):2020-2030. PubMed ID: 31112386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given 'as needed' in mild asthma: study protocols for two randomised controlled trials.
    O'Byrne PM; FitzGerald JM; Zhong N; Bateman E; Barnes PJ; Keen C; Almqvist G; Pemberton K; Jorup C; Ivanov S; Reddel HK
    Trials; 2017 Jan; 18(1):12. PubMed ID: 28069068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serious Asthma Events with Budesonide plus Formoterol vs. Budesonide Alone.
    Peters SP; Bleecker ER; Canonica GW; Park YB; Ramirez R; Hollis S; Fjallbrant H; Jorup C; Martin UJ
    N Engl J Med; 2016 Sep; 375(9):850-60. PubMed ID: 27579635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study.
    Rabe KF; Atienza T; Magyar P; Larsson P; Jorup C; Lalloo UG
    Lancet; 2006 Aug; 368(9537):744-53. PubMed ID: 16935685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Budesonide/formoterol maintenance and reliever therapy via Turbuhaler versus fixed-dose budesonide/formoterol plus terbutaline in patients with asthma: phase III study results.
    Atienza T; Aquino T; Fernández M; Boonsawat W; Kawai M; Kudo T; Ekelund J; Ivanov S; Carlsson LG
    Respirology; 2013 Feb; 18(2):354-63. PubMed ID: 23126237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment comparison of budesonide/formoterol with salmeterol/fluticasone propionate in adults aged > or =16 years with asthma: post hoc analysis of a randomized, double-blind study.
    Kuna P
    Clin Drug Investig; 2010; 30(9):565-79. PubMed ID: 20593912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial.
    Papi A; Marku B; Scichilone N; Maestrelli P; Paggiaro P; Saetta M; Nava S; Folletti I; Bertorelli G; Bertacco S; Contoli M; Plebani M; Barbaro MPF; Spanevello A; Aliani M; Pannacci M; Morelli P; Beghé B; Fabbri LM;
    Lancet Respir Med; 2015 Feb; 3(2):109-119. PubMed ID: 25481378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD.
    Rabe KF; Martinez FJ; Ferguson GT; Wang C; Singh D; Wedzicha JA; Trivedi R; St Rose E; Ballal S; McLaren J; Darken P; Aurivillius M; Reisner C; Dorinsky P;
    N Engl J Med; 2020 Jul; 383(1):35-48. PubMed ID: 32579807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial.
    Rabe KF; Pizzichini E; Ställberg B; Romero S; Balanzat AM; Atienza T; Lier PA; Jorup C
    Chest; 2006 Feb; 129(2):246-256. PubMed ID: 16478838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination formoterol and inhaled steroid versus beta2-agonist as relief medication for chronic asthma in adults and children.
    Cates CJ; Lasserson TJ
    Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD007085. PubMed ID: 19160317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of As-Needed Budesonide-Formoterol in Adolescents with Mild Asthma.
    Reddel HK; O'Byrne PM; FitzGerald JM; Barnes PJ; Zheng J; Ivanov S; Lamarca R; Puu M; Alagappan VKT; Bateman ED
    J Allergy Clin Immunol Pract; 2021 Aug; 9(8):3069-3077.e6. PubMed ID: 33895362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial.
    Papi A; Corradi M; Pigeon-Francisco C; Baronio R; Siergiejko Z; Petruzzelli S; Fabbri LM; Rabe KF
    Lancet Respir Med; 2013 Mar; 1(1):23-31. PubMed ID: 24321801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of budesonide/formoterol on demand improves asthma control by reducing exercise-induced bronchoconstriction.
    Lazarinis N; Jørgensen L; Ekström T; Bjermer L; Dahlén B; Pullerits T; Hedlin G; Carlsen KH; Larsson K
    Thorax; 2014 Feb; 69(2):130-6. PubMed ID: 24092567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma.
    Bisgaard H; Le Roux P; Bjåmer D; Dymek A; Vermeulen JH; Hultquist C
    Chest; 2006 Dec; 130(6):1733-43. PubMed ID: 17166990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.
    Pauwels RA; Löfdahl CG; Postma DS; Tattersfield AE; O'Byrne P; Barnes PJ; Ullman A
    N Engl J Med; 1997 Nov; 337(20):1405-11. PubMed ID: 9358137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.
    Scicchitano R; Aalbers R; Ukena D; Manjra A; Fouquert L; Centanni S; Boulet LP; Naya IP; Hultquist C
    Curr Med Res Opin; 2004 Sep; 20(9):1403-18. PubMed ID: 15383189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.